CVS Health Corporation (NYSE:CVS) Q2 2025 Earnings Call Transcript
Operator: Hello, and welcome to CVS Health's Second Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded today.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 16,746,853 | $1,155,197,920 | -6% | 3.76% |
| 2. | Glenview Capital Larry Robbins | 8,196,799 | $565,415,195 | -32% | 15.84% |
| 3. | Citadel Investment Group Ken Griffin | 8,176,560 | $564,019,109 | +31% | 0.1% |
| 4. | 4,660,300 | $321,467,494 | -6% | 0.06% | |
| 5. | Millennium Management Israel Englander | 4,066,670 | $280,518,897 | +10% | 0.14% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.70 | 1,570 | $100,009.00 | 12,007 | 2025-06-05 | Filing | |
| $66.70 | 30,000 | $2,001,000.00 | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | $53,879.00 | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | $500,293.81 | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | $140,930.00 | 20,630 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.67 | 150,000 | $10,000,710.00 | 8,196,799 | 2025-05-06 | Filing | |
| $67.99 | 96,999 | $6,595,272.41 | 8,346,799 | 2025-05-05 | Filing | |
| $67.37 | 1,226,933 | $82,654,672.72 | 8,443,798 | 2025-05-05 | Filing | |
| $69.66 | 373,776 | $26,035,591.55 | 9,670,731 | 2025-05-02 | Filing | |
| $68.38 | 222,556 | $15,218,980.18 | 10,044,507 | 2025-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 122,686,680 | $8,462,927,176 | 0.16% | |
| 2. | 120,399,131 | $8,305,132,057 | 0.13% | |
| 3. | 73,288,766 | $5,055,459,079 | 2.84% | |
| 4. | 66,962,583 | $4,618,953,523 | 0.67% | |
| 5. | 58,788,585 | $4,055,236,593 | 0.15% |
News See All
CVS Health Corporation (CVS) Is A Stock Going To "One Hundred Dollars!" Says Jim Cramer
CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America. The firm’s shares have gained 39% year-to-date, driven primarily by troubles at its rival Walgreens.
11 Stocks Jim Cramer Discussed As He Revealed How To Become 'King' Of AI
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer revealed what it would take to be successful in today's AI-driven world.
CVS Health Launches Happy Cappy Skincare Line Nationwide in 6,800+ Pharmacies
CVS Health Corporation (NYSE:CVS) is one of the most profitable value stocks to buy according to analysts.
CVS Health Corporation (CVS) Is A Key Part Of Weight Loss Drug Distribution, Says Jim Cramer
CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America.
10 Stocks That Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed America's latest trade deal with the European Union.
CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?
CVS Health Corporation (NYSE:CVS)’s retail pharmacy business may be widely recognized, but it represents just a small portion of its broader business.
14 Best Pharma Dividend Stocks to Buy in 2025
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain, and ongoing changes in...
Jefferies Maintains ‘Buy’ Rating on CVS Health Corporation (CVS); Raises PT
Billionaire Kerr Neilson has bought over $290,715 worth of shares in CVS Health Corporation (NYSE:CVS), representing 0.02% of his stock portfolio, securing the company a spot in Billionaire Kerr Neilson...
Billionaire Kerr Neilson’s 10 Stock Picks with Huge Upside Potential
The first half of 2025 was a roller-coaster ride for investors with the broader market surging to new highs at the beginning of the year, plunging to bearish levels, following proposed global tariffs ...